<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K799DP4&l=dataLayer" height="0" width="0" style="display:none;visibility:hidden"></iframe>
NAS:AIMT (USA) Also Trade In: Germany UK

Aimmune Therapeutics Inc $ 25.29 0 (0%)

Volume:
633,932
Avg Vol (1m):
989,863
Market Cap $:
1.58 Bil
Enterprise Value $:
1.39 Bil
P/E (TTM):
0.00
P/B:
7.67
Warning! GuruFocus has detected 1 Severe warning sign with AIMT. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)

Financial Strength

5.6/10
Current Vs Industry Vs History
Cash-To-Debt 4.72
Debt-to-Equity 0.25
Debt-to-EBITDA -0.23
N/A
Piotroski F-Score 1
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
ROIC -5304.75 %
WACC 4.7 %

Profitability

1/10
Current Vs Industry Vs History
ROE % -87.18
ROA % -70.73
ROC (Joel Greenblatt) % -741.4
3-Year EBITDA Growth Rate -25.5
3-Year EPS without NRI Growth Rate -25

Ratios

Current Vs Industry Vs History
PB Ratio 7.67
EV-to-EBIT -6.05
N/A
EV-to-EBITDA -6.11
N/A
Current Ratio 5.8
Quick Ratio 5.8

Dividend & Buy Back

Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -10.8

Valuation & Return

Current Vs Industry Vs History
Price-to-Tangible-Book 7.69
Earnings Yield (Greenblatt) % -16.51